arrow
L

Lorenzo Livi

University of Florence
H指数:50
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2

NeoCOAST-2研究中可切除肺癌的循环肿瘤DNA清除与预后

Nature
IF48.5
2026-10-250
PRE
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer

EORTC 1417 - REACTION:一项关于依托泊苷联合顺铂/卡铂,并联合或不联合帕博利珠单抗治疗初治广泛期小细胞肺癌的II期研究

2025-10-300
PRE
Intracranial activity of sotorasib vs docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer from a global, phase 3, randomized controlled trial

索托拉西布与多西他赛在经治KRAS G12C突变型晚期非小细胞肺癌中的颅内活性比较:一项全球性、III期、随机对照试验

2025-07-290
OAAI
Cardioprotection in patients with anthracycline-treated breast cancer: final analysis from the 2 × 2 randomized, placebo-controlled, double-blind SAFE trial

蒽环类药物治疗乳腺癌患者的心脏保护作用:SAFE试验2×2随机、安慰剂对照、双盲研究的最终分析

2025-06-010
PRE
Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial
2025-05-310
OAAI
Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancer

当前对于新发低体积转移性激素敏感性前列腺癌的诊断和治疗选择

2025-05-210
PRE
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study
2025-03-010
PRE
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review
2024-11-010
OAAI
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)
2024-06-0110
OAAI
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study
2024-06-012
OAAI
Re-irradiation for recurrent intracranial meningiomas: Analysis of clinical outcomes and prognostic factors
2024-06-012
PRE